Armistice AUM: Steering the Course in Health Care and Biotech Investments
In the ever-shifting terrain of healthcare investments, Armistice Capital has emerged as a notable player, particularly in pharmaceutical research. As a global value-oriented and event-driven hedge fund, Armistice has demonstrated a keen ability to navigate the complexities of the healthcare sector, positioning itself at the forefront of potentially transformative medical advancements. The current landscape of healthcare investments is characterized by […]